Randomized controlled clinical trial of lymphoblastoid interferon-α for chronic hepatitis C

Hepatology Research

Volumn 21, Issue 1, 2001, Pages 55-66

  Arase, Yasuji ^a   Chayama, Kazuaki ^b   Ikeda, Kenji ^a   Tsubota, Akihito ^a   Suzuki, Yoshiyuki ^a   Saitoh, Satoshi ^a   Kobayashi, Masahiro ^a   Suzuki, Fumitaka ^a   Akuta, Norio ^a   Someya, Takashi ^a   Kobayashi, Mariko ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis C; Interferon therapy; Randomized controlled trial

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; LYMPHOBLAST INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ANOREXIA; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT FAILURE; VIRUS LOAD;

EID: 0034902040     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(01)00073-0     Document Type: Article

References (22)

1. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection
2. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: Relationship to genotype of hepatitis C virus
3. Randomized controlled trial of lymphoblastoid interferon-alpha for chronic hepatitis C
4. Ability of prolonged interferon treatment to suppress relapse after cessation of therapy inpatients with chronic hepatitis C. A multicenter randomized controlled trial
5. Quantitative assays for chronic hepatitis C virus in serum as predictors of the long-term response to interferon
6. Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C
7. Typing six major hepatitis C virus genotypes by polymerase chain reaction using primers derived from nucleotide sequences of NS5 region
8. Hepatitis C virus genotypes: An investigation of type-specific differences in genographic origin and disease
9. Investigation of the pattern of hepatitis. C virus sequence diversity in different geographical regions: Implications for virus classification
10. Continuous versus intermittent therapy for chronic hepatitis C with recombinant interferon alpha-2a
11. Quantification of hepatitis C virus by competitive reverse transcription polymerase chain reaction: Increase of the virus in advanced liver disease
12. Classification of chronic hepatitis: Diagnosis, grading and staging
13. The long term efficacy of glycyrrhizin in chronic hepatitis C patients
14. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: A prospective observation of 2215 patients
15. Therapy of hepatitis C: Consensus interferon trials
16. A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha interferon inpatients with chronic hepatitis C
17. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
18. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
19. Efficacy and changes of the nonstructural 5A GENE by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level of serum HCV-RNA
20. Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis
21. A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia